These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 17201125)
21. Elimination of up to 80% of human pancreatic adenocarcinomas in athymic mice by cardiac hormones. Vesely DL; Eichelbaum EJ; Sun Y; Alli AA; Vesely BA; Luther SL; Gower WR In Vivo; 2007; 21(3):445-51. PubMed ID: 17591353 [TBL] [Abstract][Full Text] [Related]
22. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities. Lu YM; Shioda N; Han F; Kamata A; Shirasaki Y; Qin ZH; Fukunaga K Cardiovasc Ther; 2009; 27(1):17-27. PubMed ID: 19207476 [TBL] [Abstract][Full Text] [Related]
23. Biophytum sensitivum (L.) DC inhibits tumor cell invasion and metastasis through a mechanism involving regulation of MMPs, prolyl hydroxylase, lysyl oxidase, nm23, ERK-1, ERK-2, STAT-1, and proinflammatory cytokine gene expression in metastatic lung tissue. Guruvayoorappan C; Kuttan G Integr Cancer Ther; 2008 Mar; 7(1):42-50. PubMed ID: 18292594 [TBL] [Abstract][Full Text] [Related]
24. Cardiac hormones target nuclear oncogenes c-Fos and c-Jun in carcinoma cells. Manimala NJ; Frost CD; Lane ML; Higuera M; Beg R; Vesely DL Eur J Clin Invest; 2013 Nov; 43(11):1156-62. PubMed ID: 23992401 [TBL] [Abstract][Full Text] [Related]
25. Four peptides decrease human colon adenocarcinoma cell number and DNA synthesis via cyclic GMP. Gower WR; Vesely BA; Alli AA; Vesely DL Int J Gastrointest Cancer; 2005; 36(2):77-87. PubMed ID: 16648657 [TBL] [Abstract][Full Text] [Related]
26. Cardiac hormones activate ERK 1/2 kinases in human fibroblasts. Sun Y; Eichelbaum EJ; Wang H; Vesely DL Horm Metab Res; 2009 Mar; 41(3):197-201. PubMed ID: 18855305 [TBL] [Abstract][Full Text] [Related]
27. Mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2-dependent pathways are essential for CD8+ T cell-mediated airway hyperresponsiveness and inflammation. Ohnishi H; Takeda K; Domenico J; Lucas JJ; Miyahara N; Swasey CH; Dakhama A; Gelfand EW J Allergy Clin Immunol; 2009 Jan; 123(1):249-57. PubMed ID: 19130938 [TBL] [Abstract][Full Text] [Related]
28. New anticancer agents: hormones made within the heart. Vesely DL Anticancer Res; 2012 Jul; 32(7):2515-21. PubMed ID: 22753708 [TBL] [Abstract][Full Text] [Related]
29. Myricetin suppresses invasion and migration of human lung adenocarcinoma A549 cells: possible mediation by blocking the ERK signaling pathway. Shih YW; Wu PF; Lee YC; Shi MD; Chiang TA J Agric Food Chem; 2009 May; 57(9):3490-9. PubMed ID: 19326946 [TBL] [Abstract][Full Text] [Related]
30. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells. Bessard A; Frémin C; Ezan F; Coutant A; Baffet G J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199 [TBL] [Abstract][Full Text] [Related]
32. Vessel dilator: most potent of the atrial natriuretic peptides in decreasing the number and DNA synthesis of human squamous lung cancer cells. Vesely BA; Fitz SR; Gower WR; Vesely DL Cancer Lett; 2006 Feb; 233(2):226-31. PubMed ID: 15893414 [TBL] [Abstract][Full Text] [Related]
33. The signalling profile of recombinant human orexin-2 receptor. Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270 [TBL] [Abstract][Full Text] [Related]
34. Ontogeny of atrial natriuretic peptide and its receptor in the lung: effects on perinatal surfactant release. D'Angelis CA; Holm BA; Lakshminrusimha S; Nickerson PA; Swartz DD; Sokolowski J; Nielsen LC; Ryan RM Pediatr Res; 2008 Mar; 63(3):239-44. PubMed ID: 18287960 [TBL] [Abstract][Full Text] [Related]
35. Atrial natriuretic peptide production and natriuretic peptide receptors in the human uterus and their effect on myometrial relaxation. Cootauco AC; Murphy JD; Maleski J; Blakemore KJ; Slodzinski MK Am J Obstet Gynecol; 2008 Oct; 199(4):429.e1-6. PubMed ID: 18691685 [TBL] [Abstract][Full Text] [Related]
36. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells. Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520 [TBL] [Abstract][Full Text] [Related]
37. Non-lysosomal cycling pathway for atrial natriuretic peptide activated by protein kinase C in human NPE cells. Lehman NL; Chang AT; Crook RB Exp Eye Res; 1998 Nov; 67(5):549-59. PubMed ID: 9878217 [TBL] [Abstract][Full Text] [Related]
38. Central role of β-catenin in anticancer effects of cardiac hormones. Skelton WP; Skelton M; Vesely DL Anticancer Res; 2013 Jun; 33(6):2409-14. PubMed ID: 23749889 [TBL] [Abstract][Full Text] [Related]
39. Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts. Li P; Wang D; Lucas J; Oparil S; Xing D; Cao X; Novak L; Renfrow MB; Chen YF Circ Res; 2008 Feb; 102(2):185-92. PubMed ID: 17991884 [TBL] [Abstract][Full Text] [Related]
40. Twice-weekly intravenous treatment of pancreatic cancer with atrial natriuretic peptide and vessel dilator. Lenz A; Sun Y; Eichelbaum EJ; Skelton WP; Pi G; Vesely DL In Vivo; 2010; 24(2):125-9. PubMed ID: 20363982 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]